Pfizer Settling Celebrex, Bextra Claims: Report

Law360, New York (May 2, 2008, 12:00 AM EDT) -- Pfizer Inc. has reportedly reached tentative settlements with a number of plaintiffs who allege they suffered heart attacks and strokes from using the drugs Celebrex and Bextra, and the company may be willing to pay up to $500 million to end the litigation related to the drugs.

The Wall Street Journal reported Friday afternoon that Pfizer had reached deals with three firms representing plaintiffs in the litigation. The unnamed firms, the report said, represent more than 200 of the thousands of plaintiffs. Pfizer is also reportedly...
To view the full article, register now.